Report cover image

Global Next-Generation Sequencing (NGS) Services Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20359526

Description

Summary

According to APO Research, the global Next-Generation Sequencing (NGS) Services market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Next-Generation Sequencing (NGS) Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Next-Generation Sequencing (NGS) Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Next-Generation Sequencing (NGS) Services market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Next-Generation Sequencing (NGS) Services is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Next-Generation Sequencing (NGS) Services market include Brooks Life Sciences, Dna Link, Eurofins Scientific, Genotypic Technology, Illumina, LabCorp, Macrogen, Natera and Personalis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Next-Generation Sequencing (NGS) Services, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Next-Generation Sequencing (NGS) Services, also provides the sales of main regions and countries. Of the upcoming market potential for Next-Generation Sequencing (NGS) Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next-Generation Sequencing (NGS) Services sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Next-Generation Sequencing (NGS) Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Next-Generation Sequencing (NGS) Services sales, projected growth trends, production technology, application and end-user industry.

Next-Generation Sequencing (NGS) Services Segment by Company

Brooks Life Sciences
Dna Link
Eurofins Scientific
Genotypic Technology
Illumina
LabCorp
Macrogen
Natera
Personalis
Novogene
Berry Genomics
Roche
BGI
Next-Generation Sequencing (NGS) Services Segment by Type

Whole Exome Sequencing
Whole Genome Sequencing
Targeted Sequencing
Next-Generation Sequencing (NGS) Services Segment by Application

Biopharma Companies
Academic & Research Organizations
Hospitals and Clinics
Others
Next-Generation Sequencing (NGS) Services Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Next-Generation Sequencing (NGS) Services status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Next-Generation Sequencing (NGS) Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Next-Generation Sequencing (NGS) Services significant trends, drivers, influence factors in global and regions.
6. To analyze Next-Generation Sequencing (NGS) Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Next-Generation Sequencing (NGS) Services market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing (NGS) Services industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Services manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Next-Generation Sequencing (NGS) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Next-Generation Sequencing (NGS) Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
1.2.2 Global Next-Generation Sequencing (NGS) Services Sales Volume (2020-2031)
1.2.3 Global Next-Generation Sequencing (NGS) Services Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Next-Generation Sequencing (NGS) Services Market Dynamics
2.1 Next-Generation Sequencing (NGS) Services Industry Trends
2.2 Next-Generation Sequencing (NGS) Services Industry Drivers
2.3 Next-Generation Sequencing (NGS) Services Industry Opportunities and Challenges
2.4 Next-Generation Sequencing (NGS) Services Industry Restraints
3 Next-Generation Sequencing (NGS) Services Market by Company
3.1 Global Next-Generation Sequencing (NGS) Services Company Revenue Ranking in 2024
3.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025)
3.3 Global Next-Generation Sequencing (NGS) Services Sales Volume by Company (2020-2025)
3.4 Global Next-Generation Sequencing (NGS) Services Average Price by Company (2020-2025)
3.5 Global Next-Generation Sequencing (NGS) Services Company Ranking (2023-2025)
3.6 Global Next-Generation Sequencing (NGS) Services Company Manufacturing Base and Headquarters
3.7 Global Next-Generation Sequencing (NGS) Services Company Product Type and Application
3.8 Global Next-Generation Sequencing (NGS) Services Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Next-Generation Sequencing (NGS) Services Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Next-Generation Sequencing (NGS) Services Market by Type
4.1 Next-Generation Sequencing (NGS) Services Type Introduction
4.1.1 Whole Exome Sequencing
4.1.2 Whole Genome Sequencing
4.1.3 Targeted Sequencing
4.2 Global Next-Generation Sequencing (NGS) Services Sales Volume by Type
4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Volume by Type (2020-2031)
4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Volume Share by Type (2020-2031)
4.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Type
4.3.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020-2031)
4.3.3 Global Next-Generation Sequencing (NGS) Services Sales Value Share by Type (2020-2031)
5 Next-Generation Sequencing (NGS) Services Market by Application
5.1 Next-Generation Sequencing (NGS) Services Application Introduction
5.1.1 Biopharma Companies
5.1.2 Academic & Research Organizations
5.1.3 Hospitals and Clinics
5.1.4 Others
5.2 Global Next-Generation Sequencing (NGS) Services Sales Volume by Application
5.2.1 Global Next-Generation Sequencing (NGS) Services Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Next-Generation Sequencing (NGS) Services Sales Volume by Application (2020-2031)
5.2.3 Global Next-Generation Sequencing (NGS) Services Sales Volume Share by Application (2020-2031)
5.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Application
5.3.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020-2031)
5.3.3 Global Next-Generation Sequencing (NGS) Services Sales Value Share by Application (2020-2031)
6 Next-Generation Sequencing (NGS) Services Regional Sales and Value Analysis
6.1 Global Next-Generation Sequencing (NGS) Services Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Next-Generation Sequencing (NGS) Services Sales by Region (2020-2031)
6.2.1 Global Next-Generation Sequencing (NGS) Services Sales by Region: 2020-2025
6.2.2 Global Next-Generation Sequencing (NGS) Services Sales by Region (2026-2031)
6.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2031)
6.4.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020-2025
6.4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031)
6.5 Global Next-Generation Sequencing (NGS) Services Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
6.6.2 North America Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
6.7.2 Europe Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
6.8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
6.9.2 South America Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value (2020-2031)
6.10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value Share by Country, 2024 VS 2031
7 Next-Generation Sequencing (NGS) Services Country-level Sales and Value Analysis
7.1 Global Next-Generation Sequencing (NGS) Services Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Next-Generation Sequencing (NGS) Services Sales by Country (2020-2031)
7.3.1 Global Next-Generation Sequencing (NGS) Services Sales by Country (2020-2025)
7.3.2 Global Next-Generation Sequencing (NGS) Services Sales by Country (2026-2031)
7.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2020-2031)
7.4.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2020-2025)
7.4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.5.2 USA Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.6.2 Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.8.2 Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.9.2 France Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.9.3 France Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.11.2 Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.12.2 Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.13.2 Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.16.2 China Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.16.3 China Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.17.2 Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.19.2 India Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.19.3 India Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.20.2 Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.24.2 Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.26.2 Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.28.2 Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.29.2 UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.31.2 Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Next-Generation Sequencing (NGS) Services Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Next-Generation Sequencing (NGS) Services Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Brooks Life Sciences
8.1.1 Brooks Life Sciences Comapny Information
8.1.2 Brooks Life Sciences Business Overview
8.1.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.1.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio
8.1.5 Brooks Life Sciences Recent Developments
8.2 Dna Link
8.2.1 Dna Link Comapny Information
8.2.2 Dna Link Business Overview
8.2.3 Dna Link Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.2.4 Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio
8.2.5 Dna Link Recent Developments
8.3 Eurofins Scientific
8.3.1 Eurofins Scientific Comapny Information
8.3.2 Eurofins Scientific Business Overview
8.3.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.3.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio
8.3.5 Eurofins Scientific Recent Developments
8.4 Genotypic Technology
8.4.1 Genotypic Technology Comapny Information
8.4.2 Genotypic Technology Business Overview
8.4.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.4.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio
8.4.5 Genotypic Technology Recent Developments
8.5 Illumina
8.5.1 Illumina Comapny Information
8.5.2 Illumina Business Overview
8.5.3 Illumina Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.5.4 Illumina Next-Generation Sequencing (NGS) Services Product Portfolio
8.5.5 Illumina Recent Developments
8.6 LabCorp
8.6.1 LabCorp Comapny Information
8.6.2 LabCorp Business Overview
8.6.3 LabCorp Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.6.4 LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio
8.6.5 LabCorp Recent Developments
8.7 Macrogen
8.7.1 Macrogen Comapny Information
8.7.2 Macrogen Business Overview
8.7.3 Macrogen Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.7.4 Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio
8.7.5 Macrogen Recent Developments
8.8 Natera
8.8.1 Natera Comapny Information
8.8.2 Natera Business Overview
8.8.3 Natera Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.8.4 Natera Next-Generation Sequencing (NGS) Services Product Portfolio
8.8.5 Natera Recent Developments
8.9 Personalis
8.9.1 Personalis Comapny Information
8.9.2 Personalis Business Overview
8.9.3 Personalis Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.9.4 Personalis Next-Generation Sequencing (NGS) Services Product Portfolio
8.9.5 Personalis Recent Developments
8.10 Novogene
8.10.1 Novogene Comapny Information
8.10.2 Novogene Business Overview
8.10.3 Novogene Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.10.4 Novogene Next-Generation Sequencing (NGS) Services Product Portfolio
8.10.5 Novogene Recent Developments
8.11 Berry Genomics
8.11.1 Berry Genomics Comapny Information
8.11.2 Berry Genomics Business Overview
8.11.3 Berry Genomics Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.11.4 Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio
8.11.5 Berry Genomics Recent Developments
8.12 Roche
8.12.1 Roche Comapny Information
8.12.2 Roche Business Overview
8.12.3 Roche Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.12.4 Roche Next-Generation Sequencing (NGS) Services Product Portfolio
8.12.5 Roche Recent Developments
8.13 BGI
8.13.1 BGI Comapny Information
8.13.2 BGI Business Overview
8.13.3 BGI Next-Generation Sequencing (NGS) Services Sales, Value and Gross Margin (2020-2025)
8.13.4 BGI Next-Generation Sequencing (NGS) Services Product Portfolio
8.13.5 BGI Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Next-Generation Sequencing (NGS) Services Value Chain Analysis
9.1.1 Next-Generation Sequencing (NGS) Services Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Next-Generation Sequencing (NGS) Services Sales Mode & Process
9.2 Next-Generation Sequencing (NGS) Services Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Next-Generation Sequencing (NGS) Services Distributors
9.2.3 Next-Generation Sequencing (NGS) Services Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.